Nasdaq

Medtronic's (MDT) DEFINE AFib Study to Assess AF Burden

Medtronic plc MDT recently initiated the DEFINE AFib study to enable researchers and doctors to better understand the burden of atrial fibrillation (AF) and its impact on patient outcomes, quality of ...
Seeking Alpha

Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NTRA) (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced the results of its DEFINE-HT clinical trial in heart ...
Business Insider

Philips announces first patient enrollment in DEFINE GPS global multicenter study to assess superiority of PCI procedures guided by co-registered iFR and interventional angiography

First patient enrolled in global randomized controlled trial with up to 3,200 participants at 100 sites comparing patient outcomes after percutaneous coronary intervention (PCI) procedures guided by ...
The Hollywood Reporter

Study: Immigrant TV Characters Are More Criminalized, Less Educated Than Reality (Exclusive)

A new study from Define American, The Norman Lear Center and THR finds that immigrant characters on television tend to be more criminalized and less educated than they actually are in real life. By ...
Variety

Immigrant Stories on TV are Predominantly Latinx and About Deportation (Study)

As immigration policy continues to be a crucial topic in the news, a new report from Define American and the Norman Lear Center at USC Annenberg shows the television industry still has a long way to ...
Morningstar

Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction

DEFINE-HT is the first prospective, multicenter study in heart transplant recipients designed to assess whether elevated levels of donor-derived cell-free DNA (dd-cfDNA), as measured by Prospera Heart ...